Results 141 to 150 of about 62,812 (152)

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Exercise is medicine in oncology: Engaging clinicians to help patients move through cancer

Ca-A Cancer Journal for Clinicians, 2019
Kathryn H Schmitz, Anna M Campbell, Martijn M Stuiver   +2 more
exaly  

Yumuşak Güç ve Kültürel Etkileşim: TRT World Örneği

2021
openaire   +1 more source

Worldwide Variations in Colorectal Cancer

Ca-A Cancer Journal for Clinicians, 2009
Ahmedin Jemal
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Epidemiology and Molecular Pathology of Gallbladder Cancer

Ca-A Cancer Journal for Clinicians, 2001
Flavio Nervi
exaly  

372P Is capecitabine (CAPE) the best treatment (trt) option for estrogen receptor-positive (ER+) HER2-negative (HER2-) metastatic breast cancer (MBC) after progression on endocrine treatment (ET): An analysis of the ESME real-world database

Annals of Oncology
C. Pflumio, M. Carton, M. Debled, P.H. Cottu, M. Leheurteur, F. Dalenc, W. Jacot, A. Mailliez, B. Sauterey, C. Levy, C. Kaderbhai, O. Tredan, A. Gonçalves, L. Uwer, M. Robert, C. Bailleux, L. Cabel, S. Delaloge, L. Bosquet, T. Petit   +19 more
openaire   +1 more source

The Impact of the Internet on Cancer Outcomes

Ca-A Cancer Journal for Clinicians, 2003
Gunther Eysenbach
exaly